(2R,3S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(benzyloxy)butanoic acid, 97%, 5g

2-(4-Morpholine)ethylbromide, 95.0%, 5g

8-Fluorochroman-4-amine hydrochloride, 95.0%, 250mg

Ethyl 6-oxo-6-(4-isopropoxyphenyl)hexanoate, 97.0%, 2g

Benzyl (5,5-difluoropiperidin-3-yl)carbamate hydrochloride, 95.0%, 1g

4-(5-Chloro-2-ethoxy-4-fluorobenzamido)-3,3-dimethylbutanoic acid, 97%, 25mg

Tetraoctylammonium iodide, 98%, 1g

Nitromethane, min. 98.5%, for synthesis, 25 l, tinplate.

Ethylene Glycol, min 99%, for synthesis, 5L, plastic packaging.

6-Bromo-1H-pyrrolo[3,2-b]pyridine-3-carboxylic acid, 95.0%, 500mg

(S)-2-((S)-2-(6-(2,5-DIOXO-2H-PYRROL-1(5H)-YL)HEXANAMIDO)-3-METHYLBUTANAMIDO)PROPANOIC ACID, 95%, 1g

4-((5,6-Diphenylpyrazin-2-yl)(isopropyl)amino)butan-1-ol, 98%, 5g

N-(1-methylprop-2-yn-1-yl)cyclohexanamine, 1g